SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Ingredients News

$100m API investment a boost to Gilead's in-house capacity

28-May-2015 - Sovaldi maker Gilead Sciences has opened a new laboratory and is investing a further $100m (€91m) for API manufacturing at its site in Canada.

April US chemical output for pharma down says ACC; SOCMA welcomes R&D tax credit move

27-May-2015 - US production of chemicals for the drug industry fell in April according to data released days after renewed calls for permanent tax breaks to help American manufacturers compete globally.

Lonza set to get commercial Adva-27a contract if cancer drug is approved

27-May-2015 - Lonza shipped a sample batch of a drug for resistant cancers this week and is set produce commercial supplies if the Phase I candidate goes on to be approved says Sunshine Biopharma. 

Grace: silica gel plant certification will cut customer audit burden

26-May-2015 - WR Grace says certification for its excipient plant in Germany will reduce the audit burden faced by drug industry customers.

Home-brew morphine: Is opiate production about to get way too easy?

21-May-2015 - Access to yeast strains modified to produce opiates for cheaper, more effective pain meds must be strictly controlled according to researchers who warn that stopping criminals using such API manufacturing routes to make illegal narcotics is vital.

European freeze-drying market heats up: Symbiosis invests citing high demand

19-May-2015 - Symbiosis Pharmaceutical Services has launched a bulk freeze drying offering for APIs and intermediates, citing new contracts as a driver for the investment.

Dr Reddy’s yen for growth: Indian generics and API firm plans to partner in Japan

18-May-2015 - Dr Reddy’s has set out to build in the Japanese market days after revealing that higher generic and API sales elsewhere had been pegged back by currency fluctuations.

SAFC expands ADC and bulk drug manufacturing in CA, MO

13-May-2015 - SAFC has announced investments in gene therapy manufacturing sites in Missouri and California.

Nisso opens expanded HPC plant on back of pharma demand

11-May-2015 - Recent US FDA approval of products containing the excipient HPC has driven demand, according to Nippon Soda (Nisso) which has expanded its production facility in Japan.

Siegfried set to buy custom synthesis and API units from BASF for $300m

07-May-2015 - BASF says it remains committed to the pharma industry despite plans to divest its custom synthesis business and around 100 APIs and intermediates to Siegfried Holding.

Study finds targeting HDAC enzymes could offer hope against Alzheimer’s

06-May-2015 - A new study is shaking up ideas about a known therapeutic strategy for Alzheimer’s disease, following a discovery by scientists at Scripps Research Institute testing enzyme inhibitors.

AMRI riding high on API acquisitions, expects more M&A to come

06-May-2015 - AMRI attributed a robust first quarter to its growing API business and recent acquisitions, and says to expect more M&A activity this year.

News in brief

BASF ups price of EOAs in Europe

05-May-2015 - BASF has hiked up the price of ethanolamines in Europe citing increased cost of raw materials and continuous demand.

API firms stand to gain by seeking prequalification says the WHO

05-May-2015 - Persuading API manufacturers to seek prequalification is a challenge according to the WHO, which wants to raise awarness about the process and the positive impact it has on a suppliers' reputation.

IPEC says confusion around FDA review of excipients could delay ANDA review cycles

05-May-2015 - Inaccurate and incomplete information on excipients referenced in the US FDA Inactive Ingredient Database (IID), as well as other agency policies and guidance on the review of inactive ingredients in ANDAs (Abbreviated New Drug Applications) “continue to create confusion for the pharmaceutical industry,” according to a position paper from IPEC-Americas (International Pharmaceutical Excipients Council). 

Indian API and generics firms want a bigger share of the Japanese market

04-May-2015 - Indian generics firms see opportunities in the Japanese drug market according to a trade delegation that visited Tokyo last week seeking supply contracts.

IBEF: India still attractive for Japanese pharma despite Daiichi Sankyo's Ranbaxy experience

30-Apr-2015 - Japanese drug firms eyeing international investments should not be put off by Daiichi Sankyo’s turbulent ownership of Ranbaxy according to an Indian delegation in Tokyo last week to seek collaborations.

India’s ambition to bring home API manufacture

30-Apr-2015 - The Indian government has announced a scheme to boost home-grown production of APIs and bulk finished drugs.  

Synthesised Brussels sprouts chemical could be key to cancer combo drug

23-Apr-2015 - A small molecule combination therapy has shown promise in defeating breast cancers resistant to the usual treatments. 

Dispatches from CPHI Japan

Konnichiwa from Tokyo: in-Pharmatechnologist heads to CPHI Japan

22-Apr-2015 - The pharma world is converging on Tokyo this week and so are we to bring the latest news and views from the World’s second largest pharma market.

Update

Teva bids $40bn for Mylan in proposed generics megamerger

21-Apr-2015 - A merger with Mylan would “transform the global generics space” says Teva, which has entered a $40bn bid as an alternative to the recently proposed Mylan-Perrigo deal.

Anti-fungal shows promise for cancer breakthrough in preclinical tests

21-Apr-2015 - An anti-fungal drug shows potential to treat a range of cancers, according to research from the Repurposing Drugs in Oncology (ReDO) project, but the drugmakers will need a financial incentive to pursue a licence for new indications.

Dispatches from BPI 2015

Pfizer's vetting process sorts the strategic CMOs from the casual flings

15-Apr-2015 - Looking for a full-on partnership with Pfizer or a no-strings-attached manufacturing deal? Either way prepare for a tough screening process and don't be located too far from an airport.

API quality concerns prompt fines and drug recall orders in Taiwan

13-Apr-2015 - Thirteen Taiwanese drugmakers have been fined and ordered to recall products by regulators concerned the APIs they contain are food rather than pharma grade.

Predicting oral bioavailability is better with AI says PharmaInformatic

09-Apr-2015 - Artificial intelligence can aid lead optimisation according to the German firm behind a new structure-based drug oral bioavailability prediction technology. 

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...